Clinical Study
Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
Table 1
Demographics (ITT population).
| | Oral rabeprazole group () | IV omeprazole group () | value |
| Age (yr) | | | 0.729 | Age group | | | 0.496 | <70 yr | 43 | 38 | | ≥70 yr | 11 | 14 | | Sex (M/F) | | | 0.227 | Male | 46 | 39 | | Female | 8 | 13 | | Symptoms at presentation | | | 0.356 | Hematemesis | 11 | 7 | | Melena | 27 | 27 | | Hematochezia | 1 | 1 | | Hematemesis + melena | 12 | 12 | | Hematemesis + hematochezia | 2 | 0 | | Other | 1 | 5 | | Alcohol use | 30 | 31 | 0.698 | Smoking | 25 | 24 | 1.000 | NSAID use | 5 | 1 | 0.206 | Pulse (beats/min) | | | 0.183 | Blood pressure (mm Hg) | | | | Systolic | | | 0.111 | Diastolic | | | 0.662 | Hemoglobin (g/dL) | | | 0.569 | Hematocrit (%) | | | 0.549 | Comorbid illness | 34 | 36 | 0.543 |
|
|
ITT: intention-to-treat; IV: intravenous; NSAID: nonsteroidal anti-inflammatory drug.
|